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Abstract 
Rationale: Motor neurone disease (MND) is a neurodegenerative disease presenting with 
progressive weakness of voluntary muscles. For any condition, person-centred healthcare relies on 
the sharing of information and a mutual understanding of the person’s needs and preferences. 
Decision-making in MND becomes more complex as there is no cure and a high prevalence of co-
morbid communication and/or cognitive difficulties. 
Objective: To identify the reported impact of communication and/or cognitive impairment on 
patient and carer involvement in healthcare decision-making in MND. 
Methods: A review and synthesis of studies addressing issues of communication impairment and/or 
cognitive impairment in relation to decision-making focussed on MND was conducted. Articles 
were excluded if they were reviews, case studies, conference papers or commentaries. To be 
included studies needed to address issues of communication impairment or cognitive impairment 
specifically in relation to decision-making. Relevant data was extracted verbatim and subjected to 
content analysis to support the narrative summary.  
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Results: Seventy-six articles were identified and 35 articles screened. Six articles met inclusion 
criteria each describing examples of decision-making in MND. There was limited data related to 
communication and/or cognitive impairment and the impact these impairments may have on 
decision-making despite recognition that many people with MND may lose verbal communication 
or develop subtle cognitive impairments. The literature is primarily from the perspective of others. 
Conclusion: This review highlights that the current body of literature exploring decision-making 
within the MND population presents us with extremely limited insights into the impact of 
communication and/or cognitive impairments on healthcare decision-making. Extant literature 
focuses on interventions (namely ventilation and gastrostomy), the broad process of decision-
making, or cognitive assessment of decision-making ability. Whilst most studies acknowledge that 
deficits in communication or cognition impact the decision-making process, this issue is not the 
focus of any study.  
 
Keywords: motor neurone disease, amyotrophic lateral sclerosis, decision-making, communication 
impairment, cognitive impairment  
1. Introduction 
Person-centred healthcare decision-making uses a shared approach and is considered an ideal 
treatment decision-making process 1. Shared decision-making principles include eliciting and 
acknowledging patients’ preferences for participation, patient choices regarding how decision-
making processes will proceed, and respect and adherence of patient choices by their clinicians 1. 
This approach involves the sharing of knowledge, values and preferences, by clinicians and 
patients, to deliberate together, so that decisions are congruent with patient values and preferences 2. 
This process highlights the importance of clinicians and patients working together to facilitate 
patient autonomy 3. Decision-making becomes more complex when there are no curative treatment 
options and when there is a high prevalence of communication difficulties and a lesser prevalence 
of cognitive difficulties within a context of a rapidly progressive condition, as seen in motor 
neurone disease (MND). 
Motor neurone disease is the name given to a group of neurodegenerative diseases characterised by 
insidious onset muscle weakness with onset usually focal in the limb, bulbar or truncal musculature 
resulting in the loss of mobility and verbal communication 4. Degeneration of both upper and lower 
motor neurones causes impaired function of limbs, communication, cognition, swallowing and 
breathing 5. Disease course, site of onset and progression, as well as symptoms experienced, vary 
greatly. Although significant disease duration variability is reported, most patients die within a few 
years of symptom onset. Fifty percent of patients die within 30 months of symptom onset and 
approximately one-fifth survive between five and 10 years 6. Approximately 80-90% of people 
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diagnosed will develop a motor speech impairment 7 and current literature estimates cognitive 
deficits are present in 25-50% of patients 8. It is not clear from the literature what proportion of 
individuals with MND have communication impairment and co-occurring cognitive deficits; 
therefore throughout this paper the term communication and/or cognitive impairment will be used. 
Cognitive ability supports communication skills, consequently it is important to consider both. 
Because there is no means of halting or reversing the disease, understanding the impact of 
communication and/or cognitive impairment on healthcare decision-making is significant in this 
population, given that the clinical focus is symptom management and quality of life.  
2. Background 
Healthcare decision-making in MND is especially complex due to the nature of decisions required, 
variation in personal values and varying access to services 9. Decision-making in MND can be 
influenced by access to specialist MND care, inclusion of family carers in decisions, and patients’ 
personal reactions to their diagnosis and deterioration 10,11. Carers make a significant contribution to 
decision-making in specialist care 12,13. Deficits in communication, cognition and behaviour, as well 
as a patient’s focus on the present, can be barriers to participation in decision-making 10,11. A pro-
active approach to interventions allows for timely medical procedures (e.g. feeding tubes, 
ventilatory support) and changes to the home environment. However, making treatment decisions 
before symptoms are obvious is challenging and further complicated in the presence of frontal 
cognitive deficits. Decision-making requires effective communication and cognitive skills to make 
appropriate choices and engage in all the above. Communication and cognitive changes are 
significant to patients and carers, and are prominent in international clinical guidelines which 
recommend ongoing consideration of people’s needs to optimise communicative effectiveness, 
introduction of alternative communication devices, reassessment over the time course and 
consideration of decision-making capacity issues 4,14-16. These issues however, remain under-
researched. 
2.1. Communication impairment associated with MND 
Many people with MND will develop communication impairment. Dysarthria (difficulty speaking) 
is the most common communication impairment experienced in this population and will be 
experienced by 80-90% of people with MND 7. Dysarthria is the first or predominant sign in the 
early stage of the disease for 25-30% of patients and is eight times more frequent than dysphagia 
(difficulty swallowing) 7. Characterisation of dysarthria is based on site of involvement and the mix 
of lower and upper motor neurone features, with possible spastic, flaccid or mixed dysarthria 
occurring 7. Speech in MND is typically characterised by the presence of hyper-nasality, distorted 
articulation of constants and vowels, strained-harsh or hoarse vocal quality and slow speech rate. 
However, consistent with the highly variable nature of the disease overall, dysarthria presentation 
also varies. Some patients may only experience an isolated dysphonia (difficulty with voice 
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production), usually related to poor respiratory support for speech output. Dysphonic patients find it 
hard to communicate in groups or noisy environments or when they are talking with someone with 
hearing impairment. Associated with the upper motor neurone component, (pseudobulbar) 
dysarthria is often accompanied by emotional lability (pseudobulbar affect). This causes 
exaggerated emotional outbursts of laughing or crying, which are difficult to control and often 
inappropriate to the circumstances. When prominent, these episodes are socially disabling and 
further impair communication, especially around emotive topics. Apraxia of speech (speech sound 
disorder) (AOS), another motor speech disorder, has been identified in individuals with MND, 
albeit uncommonly. In a study of AOS in a variety of neurodegenerative disorders, a small number 
of individuals were diagnosed with MND 17. In these individuals, AOS was among the first 
symptoms of MND and was more prominent than the accompanying dysarthria.  
2.2. Cognitive impairment associated with MND 
Historically approached as a pure motor disorder, the cognitive changes associated with MND are 
becoming widely recognised and better understood 18, along with the recognition of behavioural and 
linguistic changes.  The presence of cognitive impairment can be easily missed due to patients not 
reporting difficulties, general lack of awareness of cognitive deficits by people with MND, carers 
and clinicians, or impediments to neuropsychological testing such as speech deficits, or other motor 
problems such as difficulty writing. Assessment of cognitive function may not be given high 
clinical priority in the context of a rapidly progressing disease, with medical and functional 
treatment decisions taking priority 19,20. Changes in cognitive function vary from subtle cognitive 
impairment to frank frontotemporal dementia (FTD) 8. Recent studies of patients without overt 
dementia, drawn from specialist ALS clinics in the UK, showed that a quarter of patients met the 
criteria for behavioural variant frontotemporal lobar degeneration on formal testing 18,21. 
Additionally, almost half of participants without cognitive impairment on formal cognitive screen 
presented with frontal dysfunction, behavioural change, impaired emotional processing and/or 
impaired decision-making 18,21. Apathy was the most common behaviour dysfunction reported. 
Whilst apathy is pervasive, there is no clear link to specific MND phenotypes 16. Other common 
deficits consistent with a previously reported MND cognitive profile were executive dysfunction, 
naming difficulties and impaired verbal fluency 8. Assessment of cognitive function is vital in order 
to understand patients’ cognitive capacity and to appropriately support their planning and decision-
making 19,20. 
2.3. Language impairment associated with MND 
Language impairments in MND are an emerging area of MND research. Impaired spelling, 
confrontation naming, single word comprehension, verb processing and sentence grammar have 
been found in patients with executive function scores within normal limits, meaning that executive 
dysfunction was not a contributing factor to language deficits 8,21,22. The results of these studies 
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provide evidence that language impairment is as prevalent as executive dysfunction in MND; 
however, the profiling of linguistic dysfunction is challenged by the association between language 
and executive functions, impaired speech and other motor deficits on language assessment, and 
compounded by the heterogeneity of presentations within the population. A small number of cases 
of aphasia in MND have been described in the literature with patients presenting with 
comprehension deficits, non-fluent aphasia, anomia and dysgraphia 23. In fact, changes in language 
function should be considered an important characteristic of MND and are not necessarily explained 
by an overlap of ALS and FTD 16,23. Other well described pragmatic features of communication 
dysfunction in MND include impaired social communication, impaired facial expression, emotional 
lability, and pseudobulbar affect, which all impact on interpersonal communication. The inability to 
express, or to read, social communication cues has the potential to negatively impact interpersonal 
relationships. In the context of severe physical and speech disability, familial and social 
relationships have an increased significance and correlation to quality of life 24. In this review, 
motor speech impairment, linguistic and social communication difficulties are collectively referred 
to as communication impairment. 
2.4. Impact of communication and/or cognitive impairment 
Loss of or reduced effectiveness of communication prevents patients from participating in many 
activities, can lead to social isolation, and can reduce quality of life for both patients and carers 4,25. 
Difficulty with expressive communication results in significant vulnerability and increases reliance 
on caregivers for communication support, including making healthcare decisions 25,26. The loss of 
effective communication can result in intellectual and emotional isolation for carers 4. 
Communication impairment is linked to increased medical error rates 26. Preventable adverse events 
during acute hospital admissions are three times more likely to occur in patients with a 
communication impairment than in patients without communication difficulties 27. Additionally, the 
failure to assess for cognitive deficits and decision-making capacity has significant healthcare 
implications for patients. Communication and/or cognitive difficulties may manifest as problems 
making decisions, managing finances, planning, and learning new tasks 4. Motor impairments such 
as upper limb dysfunction make writing and the use of alternative communication devices 
problematic, resulting in additional difficulties engaging in healthcare decisions without support. 
Decision-making for people with communication impairment associated with motor impairment can 
be more easily circumnavigated with alternative communication devices and communication 
strategies, whereas decision-making for people with cognitive difficulties requires more structured 
facilitation.  
There is limited understanding about the impact communication and/or cognitive impairment has on 
the decision-making process for people with MND and their carers. This is despite the high 
prevalence of these disorders in MND and numerous clinical guidelines recommending adjustments 
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to clinical care to account for patients’ communication and/or cognitive difficulties. This review 
aims to synthesise current knowledge of the impact of communication and/or cognitive impairments 
on healthcare decision-making in MND. 
3. Methods 
Search strategy and assessment 
Our review was based on a search conducted on electronic databases Medline, PsycINFO, Emcare 
and CINAHL for peer-reviewed research published in English from January 1998 to November 
2018. Search terms used were either as MESH or subject heading terms: motor neuron* disease OR 
amyotrophic lateral sclerosis AND (decision making OR advance care plan OR advance directive) 
AND (communication disorder OR cognition disorder). The reference lists of reviewed articles 
were searched to identify any further relevant research, which identified three additional studies for 
review. This is depicted schematically in Figure 1 below.  
 
Figure 1: PRISMA flow diagram summarising the literature search. 
 
To be eligible for inclusion in our review, studies need to address issues of communication 
impairment or cognitive impairment in relation to decision-making. The search included empirical 
studies and did not include reviews, case studies, conference papers or commentaries. All articles 
were identified by author CP and 20% of records screened were checked by MC to ensure they met 
eligibility for inclusion. Where appropriate, studies were evaluated using the Critical Appraisal 
Skills Program Qualitative Research Checklist (CASP) 28. This tool assesses the quality of the study 
using criteria to measure data collection and analysis, recruitment, ethical issues and overall 
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contribution of the study to the body of knowledge. The checklist confirmed four of five studies 
evidenced valid results with appropriate methodology and clear analysis methods (one study was 
not appropriate to assess using the CASP as it was published as a short Clinical/Scientific Note) 
(see Table 1 for summary). The initial intention had been to employ thematic analysis to synthesise 
the results however given the limited data available, relevant data was extracted verbatim from each 
paper and subjected to content analysis to support the narrative summary. As this review did not 
involve human subjects, ethical approval was not required. 
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Table 1. Methodological rigor of included studies (CASP Checklist28)   
Study  
(first author 
last name) 
Was there a 
clear 
statement of 
the aims of 
the 
research? 
Is a 
qualitative 
methodology 
appropriate? 
Was the 
research 
design 
appropriate 
to address 
the aims of 
the 
research? 
Was the 
recruitment 
strategy 
appropriate 
to the aims 
of the 
research? 
Was the 
data 
collected in 
a way that 
addressed 
the research 
issue? 
Has the 
relationship 
between 
researcher 
and 
participants 
been 
adequately 
considered? 
Have ethical 
issues been 
taken into 
consideration? 
Was the 
data analysis 
sufficiently 
rigorous? 
Is there a 
clear 
statement of 
findings? 
Hogden 2012 Yes Yes Yes Yes Yes No Yes Yes Yes 
Hogden 2013 Yes Yes Yes Yes Yes No Yes Yes Yes 
Lemoignan Yes Yes Yes Yes Yes Yes Yes  Yes/Can’t tell Yes 
McKelvey Yes Yes Yes Yes Yes No No Yes Yes 
Preston Yes Yes Can’t tell Yes Can’t tell No No No Can’t tell 
* Bohm 2016 not appropriate for quality assessment due to being published as a short Clinical/Scientific Notes 
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4. Results 
Seventy-six articles were identified for screening; 73 from database extraction and three additional 
articles identified from reference lists. Thirty-five articles were screened once duplications or 
studies not available in English were removed. A further 22 articles were excluded as they were a 
review, conference paper, case study or opinion piece, or based on title or abstract information. 
Thirteen articles were reviewed, with seven excluded with reason as they did not meet the inclusion 
criteria. Of the seven excluded articles, almost half discussed determinants or attitudes to shortening 
or prolonging life, or end-of-life care but did not discuss the impact of communication and/or 
cognitive impairment on patient attitude, autonomy or involvement in treatment or end-of-life care 
decision-making. The remaining articles either described the types of augmentative and alternative 
communication (AAC) that may be used in MND or described clinical assessment of cognitive 
function. 
Six articles met the criteria for this review. Five employed cross sectional, qualitative methodology 
(four employing thematic analysis, one phenomenology), two being retrospective (i.e. interviewing 
bereaved carers), and one study employed quantitative methodology (See Table 2). The papers 
within and of themselves provide rich and illustrated examples of decision-making in MND.  
However, throughout these studies there was very limited data related specifically to 
communication and/or cognitive impairment and the impact these impairments may have on 
decision-making. The literature was primarily from the perspective of others: three of the six studies 
interview carers, one study interviewed healthcare professionals, one study interviewed people with 
MND and their caregiver, and one study assessed with people with MND. 
The loss of verbal or written communication and its impact is mentioned in three studies. Bereaved 
carers report that advance care planning documents would best be done when people can talk or 
write so they are fully able to express their feelings 29. “Nudging a big button, a very slow word 
processor, is not the same as talking and I think … if we had done it [earlier, the patient] would 
have been able to express probably more forcefully her feelings" (p133). Carers felt their role to 
‘promote the patient’s voice’ was more challenging when patients lost their ability to speak 12. This 
impacted the carer’s ability to support the patient’s decision-making style and required them to 
facilitate communication between the patient and healthcare professionals. In this study, six of the 
eight carers interviewed also assumed communication responsibilities such as dealing with services, 
when their family members lost verbal communication, increasing reliance on family members 12. 
The value of AAC to support and to enable engagement in healthcare situations, for patients who 
were no longer verbal communicators was evident in McKelvey et al. (2012), “we still made 
decisions together (but) she would write instead of talk” (p238) 30.  
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The issue of cognitive impairment and its impact on decision-making is discussed in three studies. 
In a large study of 169 patients from a specialised German ALS clinic, analysis found no 
association with patients’ decisions regarding the use or decline of PEG, NIV and invasive 
ventilation or hypothetical hastened death, and cognitive impairment 31. Contrastingly, two 
qualitative studies interviewing carers and healthcare professionals both reported cognitive 
impairment impacted patients’ healthcare decision-making 12,32. Carers reported it was more 
challenging to advocate for patients, and they needed to provide additional emotional support to 
facilitate patient decision-making, when cognitive changes had occurred 12. Healthcare 
professionals identified an impact on the timing and quality of decisions, resulting in patients 
delaying decisions or making choices that may risk the well-being of carers 32. They also 
acknowledged that subtle cognitive impairment was difficult to clinically identify. For example, 
“They do have some sort of cognitive impairment which is not enough to be dementia, but they’re 
not functioning as they used to, and I’m sure it is impacting in some way” (p.694) 32. The differing 
results in these studies may reflect the methodological restriction of standardised questionnaires in 
obtaining in-depth information from participants. 
The one study interviewing people with ALS reported salient information regarding the high value 
participants placed on communication.  All participants identified communication as the most 
important factor in deciding about respiratory failure treatment options 33.  “...As long as I can 
properly communicate with my voice, my eyes or a machine or whatever, I want to have a 
respirator... But as soon as I can no longer communicate, that’s it! I don’t want anything else to be 
done” (p210). Decision-making autonomy, being involved and respected in the process and 
“wanting to have the final say” (p210) was highly important for all participants 33.
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Table 2. General information and summary of included studies 
Study Methodology Sample Primary focus of 
study 
Findings 
Medical decisions are 
independent of 
cognitive impairment 
in amyotrophic 
lateral sclerosis. 
 
Bohm et al. 2016 
Quantitative analysis 
- logistic regression 
analyses 
n=169 patients 
recruited from a 
German specialist 
outpatient clinic. 
To identify the 
possible association 
between cognitive 
and behavioural 
impairment and 
decision-making in 
ALS. 
Reported as a Clinical/Scientific note therefore findings are brief. 
- Participants were screened with the Edinburg Cognitive and Behavioural ALS 
Screen (ECAS), with 140 of participants' caregivers providing information 
regarding behavioural change. 
- Participants responded to standardised questionnaires regarding their 
decisions about percutaneous endoscopic gastrostomy (PEG), non-invasive 
ventilation (NIV) and invasive ventilation (IV). 
- Deficits in at least one cognitive domain was present in 55% of participants. 
- Caregivers reported apathy as the most commonly present behavioural change 
(15%) 
- Logistic regression analysis showed than neither cognitive impairment or 
behavioural changes were associated with participants' decisions regarding use 
or decline of PEG, NIV or IV, hypothetical ideation to turn off treatment, or wish 
for hastened death (all p > 0.05). 
 
Engaging in patient 
decision-making in 
multidisciplinary care 
for amyotrophic 
lateral sclerosis: the 
views of health 
professionals. 
 
Hogden et al. 2012 
Qualitative thematic 
analysis  
Cross sectional 
n=32 healthcare 
professionals from 
two specialised ALS 
clinics (one 
metropolitan, one 
regional) in NSW, 
Australia. 
To identify factors 
influencing patient 
decision-making 
from the 
perspectives of 
healthcare 
professionals. 
Healthcare professionals identified barriers and facilitators to decision-making 
- Barriers included; patient's acceptance of the diagnosis, types of information 
patients sourced, and patient-carer relationship. 
- Facilitators included; collaborative multidisciplinary team working, effective 
communication systems, and evidenced-based clinical information.  
- Cognitive and behavioural changes impacted quality and timing of decisions 
although patients retained decision-making capacity despite subtle cognitive 
impairment.  
- Respondents supported the introduction of routine screening for cognitive and 
behavioural changes. 
 
What are the roles of 
carers in decision-
making for 
amyotrophic lateral 
sclerosis 
multidisciplinary 
care? 
 
Hogden et al. 2013 
Qualitative thematic 
analysis  
Cross sectional 
n=8 carers of ALS 
patients from two 
specialised ALS clinics 
(one metropolitan, 
one regional) in NSW, 
Australia. 
To identify carer 
roles, and determine 
facilitators and 
barriers to carer 
participation in 
decision-making for 
ALS multidisciplinary 
care. 
- Carers made significant contributions to ALS decision-making. 
- Four common carer roles identified were; promoting the patient voice, 
promoting patient health literacy, provision of emotional support, and logistical 
assistance. 
- Facilitators and barriers to carer participation in decision-making were 
identified. 
- Changes to patient communication and cognition was identified as a barrier to 
decision-making. 
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Amyotrophic lateral 
sclerosis and assisted 
ventilation: how 
patients decide. 
 
Lemoignan et al. 
2010 
Qualitative 
phenomenology  
Cross sectional 
n=9 people with 
MND and caregivers. 
Maximum variation 
sampling. 
Recruited from a 
Canadian ALS Clinic. 
To better understand 
the experience of 
decision-making 
about assisted 
ventilation for ALS 
patients. 
- Six main themes were reported from the interviews; the meaning of the 
intervention, the importance of context, the importance of values, the effect of 
fears, the need for information, and, adaptation to or acceptance of the 
intervention. 
- Within the "importance of values" theme, participants emphasised the value of 
communication, and the ability to communicate was identified as the most 
important factor in deciding about treatment options. This influenced some 
participants’ choice of intervention.  
- Participants reported valuing decisional autonomy, and being involved and 
respected in the decision-making process. 
 
Communication 
styles of persons with 
ALS as recounted by 
surviving partners. 
 
McKelvey et al. 2012 
Qualitative thematic 
analysis 
Retrospective 
Cross sectional 
n=7 (6 bereaved 
spouses, 1 bereaved 
daughter) whose 
family members had 
used high- or low- 
tech alternative and 
augmentative 
communication 
strategies. 
Convenience 
sampling. 
Recruitment source 
not stated. 
To describe the 
communication 
patterns of 
individuals with ALS 
over time as disease 
progressed, as 
reported from the 
surviving spouses' 
perspectives. 
- Four primary themes were identified; communication styles, augmentative and 
alternative communication (AAC) use, decision-making, and lifestyle changes.  
- Loss of spoken communication was devastating to their partner, and impacted 
public and social participation. 
- Healthcare decisions were always made with input from their partners with 
ALS. 
- AAC devices were described as essential for individuals with ALS to continue 
decision-making and to facilitate participation in medical decision-making. 
The Preferred 
Priorities for Care 
(PPC) document in 
motor neurone 
disease: views of 
bereaved relatives 
and carers. 
 
Preston et al. 2012 
Qualitative thematic 
analysis  
Retrospective 
Cross sectional 
n=11 bereaved 
relatives or carers. 
Recruited from MND 
Care & Research 
Centre in 
N.W.England. 
This study examined 
bereaved relatives' 
experiences of using 
the PPC (a patient-
held record of 
advance care plans). 
Research explored 
relatives' 
perceptions about its 
impact on end-of-life 
care. 
- Four main themes were identified specific to the PPC; completion, document 
availability, important and influence on end-of-life experience, and limitations. 
- Several participants felt the PPC best completed whilst patients were able to 
write or talk 
- PPC contributed positively to end-of-life experience by providing a sense of 
relief and peace of mind, however the document had little practical impact on 
end-of-life experience due to other people's awareness of patient preferences 
irrespective of the physical document. 
- Appropriate timing of advance care planning is highly individual however is 
more effectively achieved whilst the patient retains the ability to communicate 
effectively 
- Significant role of the PPC in raising awareness of patient preferences amongst 
healthcare professionals for a patient group where effective verbal 
communication is often lost before the end of life. 
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5. Discussion 
There is a paucity of research specifically addressing the impact of communication and/or cognitive 
deficits on decision-making for people with MND and their carers. There are a number of caveats to 
the findings of those studies. The majority of the research uses cross-sectional methodology; 
however, single interviews can sometimes fail to capture the implications of ongoing change. 
Except for Bohm et al. (2016) and Hogden et al. (2012) the studies had small sample sizes. Much of 
the work obtains data from bereaved carers and whilst the experiences and perspectives of carers 
are particularly important because carers typically serve as the primary support, there remains a gap 
in the literature in regard to the direct exploration of the experiences of people with MND, 
particularly as the disease progresses. 
Although there is a significant and growing body of literature on decision-making within the MND 
population, the impact of communication and/or cognitive impairments does not emerge with any 
clarity. Instead, the broader extant literature focuses on particular interventions (namely ventilation 
and gastrostomy) 33-39; the broad process of decision-making (from the perspective of the patient, 
carer or healthcare professional) 10,12,13,32,40-42; or cognitive assessment of decision-making ability 
43,44. However, this information is rarely extrapolated to consider patients’ personal decision-
making. Almost all studies acknowledge that communication and cognition are important for 
decision-making capacity and for patient autonomy. Even though most studies acknowledged the 
need to facilitate decision-making and support communication and cognitive deficits, only two 
papers provided specific strategies. Martin et al. (2015) provide extensive strategies to support 
people with ALS and their caregivers in their decision-making (see paper for detail) 37. Strategies 
suggested by people with severe speech disabilities, including people with ALS (but not limited by 
cognitive impairments) for use with physicians in the context of primary care appointments (but 
useful in any medical or health encounter) include: allow more time for communication; tell 
patients if they’re not understood; use appropriate language and non-verbal communication; and 
speak with the patient not just the companion 45. Finally, decision-making models often fail to 
acknowledge communication and/or cognitive impairment even though they endeavour to capture 
the complexities of decision-making for patients, families, health professionals, researchers and 
policymakers 9.  
The high importance of communication to participants is apparent in the broader literature, as well 
as the articles included in this review. It is described as the most important thing, or the loss most 
felt. In a study describing the communication patterns of individuals with ALS, a bereaved carer 
reports “that was probably her biggest hurt. She couldn’t talk.” (p235) 30. Participants linked the 
ability to communicate to their values of decisional autonomy, and the importance of being 
involved and respected in the decision-making process 33. Communication needs to be prominent in 
decision-making literature and in decision-making models due to its high value to patients and 
family members, to facilitate patient autonomy, and person-centred care. 
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Timeliness of decision-making is frequently raised in the broader MND literature. A discord is 
evident between people with MND and healthcare professionals, or between people with MND and 
their family carers, with healthcare professionals and family carers often advocating for early or 
pre-emptive decisions while people with MND, either due to denial or wishing to focus on the 
present, choosing to postpone decisions 10,36,47. The importance of early decision-making is often 
justified due to the inevitable deterioration in speech function and possible development of 
cognitive deficits 20,29. Early discussions with patients and carers are recommended in international 
clinical guidelines for MND, in order to establish advance care plans or because timing is crucial to 
some intervention decisions, such as gastrostomy, which has a defined window of opportunity 
4,14,15. Early decision-making has further clinical implications, for example, the early adoption of 
AAC promotes successful implementation 48 which is why the adoption of a pro-active decision-
making style, even if not in keeping with pre-morbid decision-making approaches is encouraged 
10,48. A similar tension of timing is evident when participants were asked about information 
counselling. Patients reported valuing information, but not all wanted it before it was needed to 
make decisions which was often in contrast to family members, who report that information was a 
means to feel empowered and in control, and therefore wanted information at the onset of the 
disease 12,13,32,33. The literature supports decision-making to be largely individual, and delivered at 
the client’s pace, with generic tools or algorithms described as inappropriate 8,9,13,49. 
The studies included in this review, as well as the broader literature, highlight related points that 
affect the decision-making context for people with MND and their carers. People with MND 
experiencing communication and/or cognitive impairments rely on both carers and communication 
devices (either low-tech or high-tech) to facilitate communicative interactions such as decision-
making. However, it must be acknowledged that not all patients will have family to rely on, or who 
are able to be present for clinic appointments or involved in information sharing and decision-
making due to their own medical, financial or employment issues. This significantly increases the 
vulnerability of this group of patients. Exposure to unnecessary vulnerability is experienced by 
some patients when accessing AAC. The value of AAC to carers has been identified in reducing 
carer burden, facilitating greater rewards and social closeness, and reducing difficulty of providing 
care for people with ALS using AAC 50,51. AAC has a critical role in enabling patient autonomy, 
however challenges to accessing AAC are reported and is unacceptable. People with ALS report 
that residing in a rural location, the logistics of navigating funding support for AAC and the 
knowledge-base of their healthcare professionals all impacted AAC access and obtaining a 
communication device in a timely manner 30,46,48. This is despite evidence that early adoption 
promotes successful implementation 48; “The insurance just finally paid for his talking machine, 
shortly after he died, I finally got the check” (p237). A further barrier to access is identified by a 
bereaved carer who describes needing to set up AAC during an inpatient admission; “it’s 
unfortunate that most [hospitals] don’t know how to set up his speech equipment” (p236) 30. These 
issues clearly identify a need for education and training for various professionals involved in the 
provision and use of AAC for people with MND, and whilst AAC use may be uncommon, 
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healthcare professionals would always have access to training if their patients’ equipment related to 
the provision of medical or life survival interventions. 
This review provides further evidence that studies addressing the association between, or the impact 
of, cognitive impairment and decision-making are scarce and currently undetermined 9,31. However, 
the need to screen for cognitive changes, and the impact of cognitive changes on decision-making, 
as well the impact for carers, comes through strongly in the studies included in this review. This 
issue is reflected in international guidelines and other research, and it is clear that changes in 
cognition have implications for communication, decision-making and care provision with 
recommendations to appropriately screen and train both healthcare professionals and carers 4,15,44. 
Cognitive screening strengthens clinicians’ ability to recognise and address barriers to 
communication and decision-making, thereby enabling patient autonomy 43. Within the context of 
clinical decision-making, it appears that cognitive impairment is discussed more frequently than 
communication impairment in the broader literature. This may reflect that communication 
impairment associated with motor impairment can be more easily circumnavigated with AAC and 
communication strategies, whereas decision-making for people with cognitive difficulties requires 
more structured facilitation. It may also reflect medicolegal issues of mental capacity and capacity 
to consent in decisions. Health professionals identified both insufficient health-service funding, and 
a lack of a systematic cognitive assessment in their setting, as potential barriers to patient-centred 
decision-making 32. Historically, cognitive dysfunction in MND has not been well recognised 
resulting in a need for upskilling of healthcare professionals in the identification, screening and 
assessment of cognitive disorders. 
 
6. Conclusion and Future Directions 
This review highlights that the current body of literature exploring decision-making within the 
MND population presents us with very limited insights into the impact of communication and/or 
cognitive impairments on healthcare decision-making. From the broader literature, it is clear that 
people with MND acutely feel the loss of communication abilities, that they require personalised 
decision-making influenced by their acceptance of diagnosis and their decision-making style, that 
they rely on carers and communication devices to support their decision-making, and they require 
support and facilitation from healthcare professionals. We have identified factors that affect 
decision-making when communication and/or cognitive impairments exist such as a barrier to the 
full expression of feelings, increased reliance on carers, and the impact of timing on the quality of 
decisions.  
Until the impact of communication and/or cognitive impairments on decision-making is fully 
understood, people with MND and their carers will not be completely supported. Future research 
should focus on understanding the factors that support communication and decision-making 
effectiveness for people living with MND over the course of the disease. This is vital for patient-
centred care and to support families and carers. A longitudinal study interviewing people with 
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MND and their carers across the stages of this disease would provide insights to the real-time 
experience of making and living with decisions as time and the disabilities of MND progress.  
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